1. Home
  2. KN vs ADMA Comparison

KN vs ADMA Comparison

Compare KN & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knowles Corporation

KN

Knowles Corporation

HOLD

Current Price

$30.13

Market Cap

2.5B

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$11.32

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KN
ADMA
Founded
1946
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.4B
IPO Year
2013
2012

Fundamental Metrics

Financial Performance
Metric
KN
ADMA
Price
$30.13
$11.32
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$22.33
$25.67
AVG Volume (30 Days)
569.3K
7.3M
Earning Date
04-23-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
118.94
N/A
EPS
0.50
0.60
Revenue
$593,200,000.00
$42,219,783.00
Revenue This Year
$9.40
$27.46
Revenue Next Year
$6.98
$22.11
P/E Ratio
$62.48
$18.33
Revenue Growth
7.17
43.85
52 Week Low
$15.43
$7.21
52 Week High
$31.95
$25.67

Technical Indicators

Market Signals
Indicator
KN
ADMA
Relative Strength Index (RSI) 62.17 50.33
Support Level $23.97 $7.21
Resistance Level N/A $16.61
Average True Range (ATR) 1.06 0.49
MACD 0.25 0.36
Stochastic Oscillator 70.08 97.21

Price Performance

Historical Comparison
KN
ADMA

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: